Pharming Cash Flow Statement (2019-2026) | PHAR

Cash Flow Statement Dec2019 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-17.81M15.19M3.60M21.59M9.50M37.90M-18.13M-13.29M3.15M-12.01M-20.49M-3.02M1.51M-5.14M-13.03M5.63M26.09M4.30-14.26M28.01M
Share-based Compensation (Quarter)
-3.70M1.91M1.64M1.07M1.97M3.32M2.92M2.64M4.51M
Gains from Sales and Divestitures (Quarter)
0.02M-3.73M
Non-cash Items (Quarter)
-25.10M9.00M11.69M6.08M-21.75M7.83M-2.57M9.73M18.66M46.85M
Cash from Discontinued Operations (Quarter)
5.51M7.06M12.62M0.61M-32.41M3.53M-17.30M9.74M-1.79M54.71M
Change in Working Capital (Quarter)
0.04M-1.09M2.40M-5.42M-1.74M1.05M-1.08M7.35M-10.07M14.08M
Change in Receivables (Quarter)
4.65M2.96M4.05M-1.46M-5.54M-7.36M-18.54M2.92M-6.78M1.77M1.56M-3.35M
Change in Inventory (Quarter)
-0.80M-0.61M0.42M-2.30M-10.72M-0.40M-14.43M-2.13M-0.50M-1.29M
Change in Account Payables (Quarter)
-0.99M-4.01M-2.33M-1.65M3.24M8.15M6.56M-2.77M17.82M
Change in Taxes (Quarter)
-1.55M2.60M
Cash from Operations (Quarter)
5.51M7.06M12.62M0.61M-32.41M3.53M-17.30M9.74M-1.79M10.71M
Depreciation, Depletion & Amortization
Amortization of Goodwill (Quarter)
-0.63M
Depreciation & Amortization (CF) (Quarter)
-4.41M2.06M1.95M2.19M2.90M7.55M2.74M16.07M11.22M
Investing Activities
Capital Expenditures (Quarter)
-2.02M-1.96M-0.34M-0.21M-0.99M-0.15M-1.44M-0.37M-0.79M-0.75M
Change in Intangibles (Quarter)
-0.34M-0.46M0.24M-0.17M-0.03M-0.01M-0.01M
Acquisitions (Quarter)
5.87M6.13M
Change in Acquisitions & Divestments (Quarter)
-87.35M146.36M114.50M314.63M85.00M
Cash from Investing Activities (Quarter)
-7.39M-2.56M-0.30M-0.38M-67.25M-58.23M-129.39M4.35M-9.79M-0.04M
Financing Activities
Other financing activities (Quarter)
0.02M-0.32M0.25M-0.02M-0.05M-0.22M-0.02M-5.87M-8.12M-0.28M-5.87M-7.94M
Cash from Financing Activities (Quarter)
-2.84M-2.38M-1.92M-2.89M-5.26M5.24M-1.04M-1.43M-34.41M1.04M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
5.87M7.74M7.29M5.87M6.13M
Dividend Payments
Dividends Paid - Common (Quarter)
-8.12M-7.88M-5.87M-7.94M
Additional items
Exchange Rate Effect (Quarter)
4.40M-0.65M-11.66M0.41M-0.91M0.44M-2.21M1.24M
Change in Cash (Quarter)
-4.72M2.12M10.40M-2.65M-104.92M-49.46M-147.73M12.66M-4.59M11.70M
Free Cash Flow (Quarter)
7.53M0.05M12.96M0.82M-31.42M3.67M-15.87M10.11M-1.00M11.46M
Net Cash Flow (Quarter)
-4.72M-0.01M10.40M-2.65M-104.92M-49.46M-147.73M12.66M-46.00M11.70M